Platelet activating factor potentiates rat paw oedema induced by different phlogogen agents

Area of Science:

• Pharmacology
• Inflammation Research
• Immunology

Background:

• Carrageenan-induced paw oedema is a common model for studying acute inflammation.
• Platelet-activating factor (PAF) is a potent lipid mediator implicated in various inflammatory processes.
• The interaction of PAF with other inflammatory mediators in this model is not fully understood.

Purpose of the Study:

• To investigate the role of platelet-activating factor (PAF) in modulating carrageenan-induced paw oedema.
• To determine if PAF enhances oedema induced by other inflammatory agents.
• To explore the mechanisms underlying PAF-induced enhancement of oedema.

Main Methods:

• Carrageenan was injected into the rat paw to induce oedema.
• Platelet-activating factor (PAF) was co-injected with carrageenan or other inflammatory agents.
• The effects of verapamil and BN 52021 on PAF-induced enhancement were evaluated.
• Experiments were conducted in essential fatty acid-deficient (EFAD) rats depleted of kininogen and amines.

Main Results:

• Simultaneous injection of PAF significantly enhanced carrageenan-induced paw oedema.
• PAF also enhanced oedema induced by dextran, cellulose sulphate, histamine, 5-hydroxytryptamine, bradykinin, and prostaglandin E2.
• Both verapamil and BN 52021 abolished the oedema enhancement induced by PAF.
• In EFAD rats, PAF did not modify carrageenan-induced oedema.

Conclusions:

• Platelet-activating factor (PAF) potentiates inflammatory responses mediated by various agents.
• The PAF-induced enhancement of oedema appears to involve interactions with other inflammatory mediators, possibly kininogen and amines.
• Verapamil and BN 52021 may act by inhibiting PAF-mediated inflammatory pathways.